近年来，应用骨骼肌成肌细胞心肌内移植替代损伤心肌及疤痕组织的研究取得了很大进展，受到广泛关注。
Recently, the research on applying skeletal muscle myoblast to transplant within the myocardium to replace the damaged myocardium and scar tissue developed greatly and are widely paid attention to.
如何减少心肌细胞凋亡已成为心肌保护的研究热点之一，随着研究的不断深入，其在心肌缺血再灌注损伤中应用具有广泛的前景。
How to reduce myocardial apoptosis is one of the hot spots in myocardial preservation. With the deepening study, its application in myocardial ischemia-reperfusion injury will have wide prospective.
心肌损伤生物标志物的检测在心脏疾病临床诊断上被广泛应用，但是在新药的非临床安全评价方面，心肌损伤标志物的应用相对滞后。
The biomarkers of myocardial injury are used widely in clinical diagnosis of heart diseases. However, application of the biomarker in drug preclinical safety evaluation is relatively less.
心肌损伤生物标志物的检测在心脏疾病临床诊断上被广泛应用，但是在新药的非临床安全评价方面，心肌损伤标志物的应用相对滞后。
The biomarkers of myocardial injury are used widely in clinical diagnosis of heart diseases. However, application of the biomarker in drug preclinical safety evaluation is relatively less.
应用推荐